Skip to Main Content

Advertisement

Skip Nav Destination

JHI is a Gold Open Access journal that publishes papers that provide novel insights into the physiology and pathology of human immunity through the study of genetic defects and their phenocopies

Newest Articles
Article
Jonas Lønskov, Annika Sünderhauf et al.
Here, Lønskov et al. describe a child homozygous for a deleterious variant in PARK7/DJ-1 presenting with RSV infection, brain inflammation, and seizures and explore the pathophysiology of PARK7 deficiency, underscoring the importance of PARK7 in human immune regulation and homeostasis.
Research Letter
Katherine Hickey, Conor Gruber et al.
Children with bronchiolitis exhibit a unique immunophenotype. We identify a significant difference in plasmacytoid dendritic cells and eosinophils in hospitalized patients as compared to controls, as well as cytokines involved in airway inflammation that are significantly different in hospitalized patients as compared to controls.
Article
Nina N. Brodsky, Alan Kennedy et al.
We describe a novel CTLA-4 p.Tyr218* variant associated with immune dysregulation across four generations. The mutation truncates the cytoplasmic tail, reducing CTLA-4 stability and transendocytosis, consistent with haploinsufficiency and autoimmunity. These findings suggest an important role for the C-terminal domain of CTLA-4 in maintaining immune homeostasis.
Research Letter
Quentin Philippot, Marie-Pierre Debray et al.
We report a case of chronic pulmonary SARS-CoV2 infection caused by impaired B cell–mediated immunity to SARS-CoV-2 in a patient with Good syndrome. Immunoglobulin replacement therapy alone was sufficient to achieve clinical and radiological resolution.
Article
Aparna Dalvi, Lavina Temkar et al.
Dalvi et al. report on 50 Indian patients with Mendelian susceptibility to mycobacterial disease (MSMD), highlighting its clinical diversity and genetic heterogeneity. The study demonstrates how immunological assays and flow cytometry, combined with genetic testing, enable timely and accurate diagnosis of MSMD, aiding targeted clinical management.
Article
Virdette L. Brumm, Sharon A. Kidd et al.
We evaluated 69 subjects with SCID to assess the neurodevelopmental outcomes following HCT. Compared with the normative population, our subjects performed in the average range. There was no impact of newborn screening, conditioning, or genotype. Families earning <$50,000 had poorer outcomes. Our study provides the most substantial, comprehensive analysis of ND outcomes for SCID.
Research Letter
Chen Wang, Meera Patel et al.
PGM3 deficiency is a multisystem disorder characterized by recurrent infections, chronic severe neutropenia, and virus-associated malignancies, often leading to premature mortality in early adulthood. These features strongly support early consideration of hematopoietic stem cell transplantation in affected individuals.
Journal of Human Immunity Cover Image for Volume 1, Issue 4
Current Issue
Volume 1,
Issue 4,
3 November 2025
Reviews & Opinions
How I Treat
Alexandra F. Freeman, Beth K. Thielen et al.
Freeman et al. provide practical advice on prevention, diagnosis, and management of infections in inborn errors of immunity as well as management of common complications such as bronchiectasis.
Review
Ricardo Martins-Ferreira, Esteban Ballestar
Martins-Ferreira and Ballestar review how ICF syndrome serves as a paradigm of epigenetic immunodeficiency. They show how alterations in DNA methylation and chromatin remodeling disrupt genome stability and B cell maturation, highlighting broader principles linking epigenetic regulation to immunity and informing other primary immunodeficiencies.
Review
Tom Le Voyer, Jean-Laurent Casanova et al.
This review synthesizes human inborn errors of the alternative NF-κB pathway-affecting core components, upstream ligands/receptors, or regulators, or regulatory elements-highlighting their shared and distinct effects on lymphoid development, immune dysregulation, and mTEC-mediated tolerance, which can lead to impaired B and T cell function, the development of neutralizing anti-type I IFN autoantibodies, susceptibility to severe viral diseases, and syndromic features.

Most Read

Advertisement

JHI is a partnership between the International Alliance for Primary Immunodeficiency Societies (IAPIDS) and Rockefeller University Press (RUP) and is the official journal of IAPIDS and its member societies. Learn more about the origins of JHI.

null
logos of member organizations
null

or Create an Account

Close Modal
Close Modal